Home Assay of oxidized fibrinogen reactivity (OFR) as a biomarker of oxidative stress in human plasma: the role of lysine analogs
Article
Licensed
Unlicensed Requires Authentication

Assay of oxidized fibrinogen reactivity (OFR) as a biomarker of oxidative stress in human plasma: the role of lysine analogs

  • László Selmeci , Leila Seres , Mária Székely , Pál Soós and György Acsády
Published/Copyright: February 1, 2010

Abstract

Background: There is accumulating evidence that fibrinogen is also a biomarker of oxidative stress in human plasma. Results of in vitro studies demonstrated that fibrinogen can bind to apolipoprotein(a) [apo(a)] component of lipoprotein(a) [Lp(a)] through both lysine-sensitive and lysine-insensitive mechanisms. The goal of the present study was to investigate oxidized fibrinogen reactivity (OFR) as a biomarker of oxidative stress in human plasma in the presence and absence of lysine analogs.

Methods: Citrate anticoagulated peripheral venous blood samples were collected from 65 (36 M/29 F) consecutive patients with various peripheral vascular diseases. After centrifugation, the plasma was used promptly. Plasma OFR was determined in duplicate using a recently described kinetic photometric assay (358 nm, 37°C) in the presence and in the absence of lysine analogs.

Results: The inclusion of tranexemic acid (TRA) or ε-aminocaproic acid in the incubation medium resulted in a rapid increase in OFR in a dose-dependent manner. The peak effect was observed at a final concentration of 200 mmol/L TRA. OFR was significantly higher in patient plasma assayed in the presence of TRA compared with no TRA (163.1±73.5 vs. 63.4±20.7 U/L; p<0.0001). Bound OFR was also significantly higher than free OFR (99.7±56.3 vs. 63.4±20.7; p<0.001).

Conclusions: On the basis of the present results it appears that oxidized fibrinogen resides in plasma in two compartments: free and bound to apo(a) of Lp(a). The relatively simple and cost-effective kinetic approach applied in this study makes routine determination of OFR available as a biomarker of oxidative stress, separately in both compartments.

Clin Chem Lab Med 2010;48:379–82.


Corresponding author: Prof. László Selmeci, MD, PhD, DSc, Department of Vascular Surgery, Semmelweis University, Faculty of Medicine, Városmajor u. 68, 1122 Budapest, Hungary Fax: +3614586746,

Received: 2009-9-28
Accepted: 2009-11-10
Published Online: 2010-02-1
Published in Print: 2010-03-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. Standardization of assays for clinically important enzymes that have high biologic variation: what is all the fuss about?
  3. Minireview
  4. Standardization in clinical enzymology: a challenge for the theory of metrological traceability
  5. Review
  6. Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis?
  7. Opinion Paper
  8. The underestimated problem of using serum magnesium measurements to exclude magnesium deficiency in adults; a health warning is needed for “normal” results
  9. Genetics and Molecular Diagnostics
  10. Integrated PCR amplification and detection processes on a Lab-on-Chip platform: a new advanced solution for molecular diagnostics
  11. Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility
  12. Association of the CD28/CTLA4/ICOS polymorphisms with susceptibility to rheumatoid arthritis
  13. Lack of association between DAZ gene methylation patterns and spermatogenic failure
  14. General Clinical Chemistry and Laboratory Medicine
  15. Evaluation of five routine glucose methods on an Olympus AU5400 analyzer using the CDC hexokinase reference method
  16. Multicentre evaluation of the Tosoh HbA1c G8 analyser
  17. Performance of a fully automated quantitative neopterin measurement assay in a routine voluntary blood donation setting
  18. Assay of oxidized fibrinogen reactivity (OFR) as a biomarker of oxidative stress in human plasma: the role of lysine analogs
  19. Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome
  20. Development and validation of a high performance liquid chromatography method to determine linezolid concentrations in pig pulmonary tissue
  21. Is heparin plasma suitable for the determination of B-type natriuretic peptide on the Beckman-Coulter Access 2?
  22. Composition of kidney stone fragments obtained after extracorporeal shock wave lithotripsy
  23. Reference Values and Biological Variations
  24. Gender does not influence cystatin C concentrations in healthy volunteers
  25. Stability of serum thyroid hormones following 8–11 years of cold storage
  26. Infectious Diseases
  27. Detection and quantitation of Epstein-Barr virus (EBV) DNA in EDTA whole blood samples using automated sample preparation and real time PCR
  28. Letters to the Editor
  29. The polymorphisms –1131T>C and the S19W of the APOA5 gene are not associated with coronary artery disease in a Brazilian population
  30. Tissue factor +5466A>G and –1208D>I genetic polymorphisms and severity of rheumatoid arthritis
  31. Ability of deferasirox to bind iron during measurement of iron
Downloaded on 8.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.076/html
Scroll to top button